-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$6.00466.04% Upside
Lexicon Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Lexicon Pharmaceuticals, Inc.?
Lexicon Pharmaceuticals, Inc. has been rated by research analysts at Leerink Partners in the past 90 days.